

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 5.11383512 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.18046919 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.18046919 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 4.18046919 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.18046919 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.18046919 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.18046919 |
| 8 | positive regulation of histone deacetylation (GO:0031065) | 4.10095422 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.06113343 |
| 10 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.99542498 |
| 11 | response to peptidoglycan (GO:0032494) | 3.96896795 |
| 12 | sarcomere organization (GO:0045214) | 3.93680223 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 3.82668562 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 3.81688912 |
| 15 | cardiac myofibril assembly (GO:0055003) | 3.78576178 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.75083661 |
| 17 | negative regulation of cell size (GO:0045792) | 3.74579651 |
| 18 | germinal center formation (GO:0002467) | 3.72475310 |
| 19 | response to muramyl dipeptide (GO:0032495) | 3.63793516 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.61409994 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.58334223 |
| 22 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.48985406 |
| 23 | protein localization to endosome (GO:0036010) | 3.45204502 |
| 24 | detection of other organism (GO:0098543) | 3.44978171 |
| 25 | NIK/NF-kappaB signaling (GO:0038061) | 3.42347519 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.41455147 |
| 27 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.38936943 |
| 28 | cellular extravasation (GO:0045123) | 3.36785928 |
| 29 | adherens junction assembly (GO:0034333) | 3.36108494 |
| 30 | B cell receptor signaling pathway (GO:0050853) | 3.32337766 |
| 31 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.29085017 |
| 32 | positive T cell selection (GO:0043368) | 3.28909019 |
| 33 | detection of bacterium (GO:0016045) | 3.28860410 |
| 34 | actin-myosin filament sliding (GO:0033275) | 3.28711251 |
| 35 | muscle filament sliding (GO:0030049) | 3.28711251 |
| 36 | myofibril assembly (GO:0030239) | 3.28558306 |
| 37 | thymic T cell selection (GO:0045061) | 3.26679814 |
| 38 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.25892221 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.25718457 |
| 40 | morphogenesis of an endothelium (GO:0003159) | 3.24782633 |
| 41 | endothelial tube morphogenesis (GO:0061154) | 3.24782633 |
| 42 | pre-miRNA processing (GO:0031054) | 3.24591036 |
| 43 | focal adhesion assembly (GO:0048041) | 3.22902787 |
| 44 | cell-substrate adherens junction assembly (GO:0007045) | 3.22902787 |
| 45 | mannose metabolic process (GO:0006013) | 3.20249652 |
| 46 | NLS-bearing protein import into nucleus (GO:0006607) | 3.17050068 |
| 47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16858635 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.13244205 |
| 49 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.12546214 |
| 50 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.12089975 |
| 51 | peptidyl-lysine dimethylation (GO:0018027) | 3.08840666 |
| 52 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.06244791 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.04976981 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.03213288 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99235462 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 2.97835524 |
| 57 | detection of external biotic stimulus (GO:0098581) | 2.97780715 |
| 58 | regulation of p38MAPK cascade (GO:1900744) | 2.96741125 |
| 59 | response to laminar fluid shear stress (GO:0034616) | 2.95797055 |
| 60 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.94207545 |
| 61 | negative regulation of cell killing (GO:0031342) | 2.94207545 |
| 62 | regulation of leukocyte degranulation (GO:0043300) | 2.93292199 |
| 63 | myeloid dendritic cell differentiation (GO:0043011) | 2.90874376 |
| 64 | stress fiber assembly (GO:0043149) | 2.90776060 |
| 65 | cardiac muscle contraction (GO:0060048) | 2.89687951 |
| 66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.88731264 |
| 67 | leukocyte aggregation (GO:0070486) | 2.88168301 |
| 68 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.88155760 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 2.88063570 |
| 70 | cell-substrate junction assembly (GO:0007044) | 2.87520773 |
| 71 | regulation of ARF GTPase activity (GO:0032312) | 2.86912432 |
| 72 | positive regulation of myotube differentiation (GO:0010831) | 2.86658831 |
| 73 | carnitine shuttle (GO:0006853) | 2.86507335 |
| 74 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.86054642 |
| 75 | T cell selection (GO:0045058) | 2.85613360 |
| 76 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.85132949 |
| 77 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84999734 |
| 78 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.84999734 |
| 79 | T cell migration (GO:0072678) | 2.82978689 |
| 80 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.82229915 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 2.80529378 |
| 82 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.80228170 |
| 83 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.79291558 |
| 84 | negative regulation of heart growth (GO:0061117) | 2.79291558 |
| 85 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.77155504 |
| 86 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.77011939 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76701259 |
| 88 | tolerance induction (GO:0002507) | 2.75567444 |
| 89 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.75394814 |
| 90 | positive regulation of protein deacetylation (GO:0090312) | 2.71583253 |
| 91 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.71536037 |
| 92 | actomyosin structure organization (GO:0031032) | 2.70574188 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70372691 |
| 94 | T-helper 1 type immune response (GO:0042088) | 2.68865432 |
| 95 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66457036 |
| 96 | response to host immune response (GO:0052572) | 2.66457036 |
| 97 | detection of biotic stimulus (GO:0009595) | 2.66376368 |
| 98 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.66194483 |
| 99 | type I interferon signaling pathway (GO:0060337) | 2.65844053 |
| 100 | cellular response to type I interferon (GO:0071357) | 2.65844053 |
| 101 | positive regulation of B cell differentiation (GO:0045579) | 2.65100349 |
| 102 | response to type I interferon (GO:0034340) | 2.65007692 |
| 103 | defense response to protozoan (GO:0042832) | 2.64818283 |
| 104 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.64798745 |
| 105 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64701657 |
| 106 | response to host (GO:0075136) | 2.64701657 |
| 107 | response to host defenses (GO:0052200) | 2.64701657 |
| 108 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.64213809 |
| 109 | negative regulation of fatty acid transport (GO:2000192) | 2.63656810 |
| 110 | myeloid dendritic cell activation (GO:0001773) | 2.63598754 |
| 111 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.63579585 |
| 112 | fatty acid transmembrane transport (GO:1902001) | 2.62012432 |
| 113 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.61757928 |
| 114 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.61468898 |
| 115 | B cell homeostasis (GO:0001782) | 2.61018244 |
| 116 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.60279141 |
| 117 | regulation of tolerance induction (GO:0002643) | 2.59880214 |
| 118 | modulation by symbiont of host cellular process (GO:0044068) | 2.59477691 |
| 119 | cortical actin cytoskeleton organization (GO:0030866) | 2.58915250 |
| 120 | macrophage activation (GO:0042116) | 2.58745429 |
| 121 | actin filament-based movement (GO:0030048) | 2.58567647 |
| 122 | negative regulation of T cell mediated immunity (GO:0002710) | 2.57633419 |
| 123 | negative thymic T cell selection (GO:0045060) | 2.57493926 |
| 124 | regulation of antigen processing and presentation (GO:0002577) | 2.57430961 |
| 125 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.55341618 |
| 126 | pinocytosis (GO:0006907) | 2.55099816 |
| 127 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.54906949 |
| 128 | regulation of ARF protein signal transduction (GO:0032012) | 2.54509502 |
| 129 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.54234819 |
| 130 | response to protozoan (GO:0001562) | 2.53423999 |
| 131 | negative T cell selection (GO:0043383) | 2.53421607 |
| 132 | myeloid cell activation involved in immune response (GO:0002275) | 2.52532028 |
| 133 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.51932768 |
| 134 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.51736069 |
| 135 | positive regulation of mast cell activation (GO:0033005) | 2.51660944 |
| 136 | maternal placenta development (GO:0001893) | 2.51363564 |
| 137 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.50869229 |
| 138 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.50568984 |
| 139 | positive regulation of type 2 immune response (GO:0002830) | 2.50474490 |
| 140 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.50420505 |
| 141 | regulation of tight junction assembly (GO:2000810) | 2.48942118 |
| 142 | regulation of translational fidelity (GO:0006450) | 2.48904003 |
| 143 | striated muscle contraction (GO:0006941) | 2.48881496 |
| 144 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.48569743 |
| 145 | histone H3-K36 demethylation (GO:0070544) | 2.47370702 |
| 146 | barbed-end actin filament capping (GO:0051016) | 2.46829700 |
| 147 | layer formation in cerebral cortex (GO:0021819) | 2.46476671 |
| 148 | actin-mediated cell contraction (GO:0070252) | 2.46267686 |
| 149 | activation of JUN kinase activity (GO:0007257) | 2.45090563 |
| 150 | negative regulation of granulocyte differentiation (GO:0030853) | 2.44915176 |
| 151 | positive regulation of antigen processing and presentation (GO:0002579) | 2.44266310 |
| 152 | regulation of necroptotic process (GO:0060544) | 2.44227077 |
| 153 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.44167608 |
| 154 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.43905108 |
| 155 | apoptotic process involved in morphogenesis (GO:0060561) | 2.42661968 |
| 156 | heart trabecula formation (GO:0060347) | 2.42538631 |
| 157 | glycosphingolipid catabolic process (GO:0046479) | 2.41640229 |
| 158 | cardiac muscle cell development (GO:0055013) | 2.40064267 |
| 159 | regulation of fatty acid oxidation (GO:0046320) | 2.39373386 |
| 160 | creatine metabolic process (GO:0006600) | 2.38403412 |
| 161 | positive regulation of RNA splicing (GO:0033120) | 2.37405240 |
| 162 | mRNA stabilization (GO:0048255) | 2.35981347 |
| 163 | RNA stabilization (GO:0043489) | 2.35981347 |
| 164 | negative regulation of catenin import into nucleus (GO:0035414) | 2.34603338 |
| 165 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.33229459 |
| 166 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.32702529 |
| 167 | growth hormone receptor signaling pathway (GO:0060396) | 2.31996046 |
| 168 | cell communication by electrical coupling (GO:0010644) | 2.31800478 |
| 169 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.31139359 |
| 170 | cardiac cell development (GO:0055006) | 2.30076650 |
| 171 | negative regulation of histone methylation (GO:0031061) | 2.29791283 |
| 172 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.27689881 |
| 173 | regulation of skeletal muscle contraction (GO:0014819) | 2.27082604 |
| 174 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 2.25946831 |
| 175 | peptidyl-threonine phosphorylation (GO:0018107) | 2.25389000 |
| 176 | 2-oxoglutarate metabolic process (GO:0006103) | 2.24995701 |
| 177 | semaphorin-plexin signaling pathway (GO:0071526) | 2.24756469 |
| 178 | positive regulation of glycogen metabolic process (GO:0070875) | 2.22767199 |
| 179 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.21283215 |
| 180 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.20110887 |
| 181 | natural killer cell differentiation (GO:0001779) | 2.19446225 |
| 182 | oxaloacetate metabolic process (GO:0006107) | 2.19349882 |
| 183 | peptidyl-threonine modification (GO:0018210) | 2.19333901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.92454791 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.85849460 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.37311057 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.31943489 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 3.11645155 |
| 6 | KDM2B_26808549_Chip-Seq_DND41_Human | 3.08654324 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.93255551 |
| 8 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.76182300 |
| 9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.74490756 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67525395 |
| 11 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.64654890 |
| 12 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.59323684 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.54720377 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.53211256 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43389432 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.38816576 |
| 17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37912929 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.34326734 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.27715351 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.26321153 |
| 21 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.22169506 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.16671461 |
| 23 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 2.15265381 |
| 24 | * KDM2B_26808549_Chip-Seq_K562_Human | 2.05275269 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.00562650 |
| 26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.98519304 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97706300 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95251250 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.95165115 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.90168889 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89127951 |
| 32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87036033 |
| 33 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.84505694 |
| 34 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.79539641 |
| 35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78394781 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75442751 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.75387617 |
| 38 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.75119373 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73959601 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72867158 |
| 41 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.72658639 |
| 42 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.71445884 |
| 43 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.71445884 |
| 44 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71042036 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.71023969 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69903642 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67091892 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.66805173 |
| 49 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.65866407 |
| 50 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.64320057 |
| 51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63809795 |
| 52 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.63140940 |
| 53 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.60976608 |
| 54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.59845970 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.57923222 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57221158 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52398856 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50632529 |
| 59 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50466584 |
| 60 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.44546896 |
| 61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.42109534 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41823371 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.36900968 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.36866549 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35995851 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35261537 |
| 67 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.33722029 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.33198291 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33070264 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.32512686 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32176705 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32116143 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31665924 |
| 74 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.31307016 |
| 75 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30930001 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30247152 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30235087 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30115050 |
| 79 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29227602 |
| 80 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.28831148 |
| 81 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.27692861 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25628425 |
| 83 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25315835 |
| 84 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24935827 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24738588 |
| 86 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24224712 |
| 87 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22969770 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21816534 |
| 89 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20275607 |
| 90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19934292 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18255144 |
| 92 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17198398 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15327969 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15021902 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14975789 |
| 96 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14596757 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14548086 |
| 98 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13377368 |
| 99 | MYB_26560356_Chip-Seq_TH1_Human | 1.13316277 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13107658 |
| 101 | P68_20966046_ChIP-Seq_HELA_Human | 1.13098036 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12173721 |
| 103 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.11790129 |
| 104 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09626237 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09481073 |
| 106 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09424337 |
| 107 | MYB_26560356_Chip-Seq_TH2_Human | 1.08575859 |
| 108 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08176986 |
| 109 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.08114664 |
| 110 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07344927 |
| 111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07264763 |
| 112 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06987751 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06546354 |
| 114 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05996386 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04970174 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04940200 |
| 117 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01399858 |
| 118 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.00988439 |
| 119 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00791028 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97491323 |
| 121 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.96551423 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96011379 |
| 123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95943313 |
| 124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95361708 |
| 125 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93649570 |
| 126 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93128266 |
| 127 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92624981 |
| 128 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92277752 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91255654 |
| 130 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90697166 |
| 131 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90016932 |
| 132 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89594822 |
| 133 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88269799 |
| 134 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87971663 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87891640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.81097303 |
| 2 | MP0000751_myopathy | 3.55434837 |
| 3 | MP0003436_decreased_susceptibility_to | 3.46661762 |
| 4 | MP0003303_peritoneal_inflammation | 3.12922661 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.11994845 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.86040674 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.83589611 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.79540218 |
| 9 | MP0003646_muscle_fatigue | 2.73614580 |
| 10 | MP0005451_abnormal_body_composition | 2.70870910 |
| 11 | MP0004130_abnormal_muscle_cell | 2.70716210 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.66974441 |
| 13 | MP0004510_myositis | 2.59262246 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.50940289 |
| 15 | MP0005076_abnormal_cell_differentiation | 2.47878819 |
| 16 | MP0002419_abnormal_innate_immunity | 2.46544166 |
| 17 | MP0003724_increased_susceptibility_to | 2.46503232 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.46185465 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.45625057 |
| 20 | MP0005671_abnormal_response_to | 2.43710147 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 2.38540381 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 2.35474015 |
| 23 | MP0000749_muscle_degeneration | 2.32188774 |
| 24 | MP0008961_abnormal_basal_metabolism | 2.25221296 |
| 25 | MP0000733_abnormal_muscle_development | 2.24358967 |
| 26 | MP0009840_abnormal_foam_cell | 2.23813694 |
| 27 | MP0006082_CNS_inflammation | 2.23543570 |
| 28 | MP0005025_abnormal_response_to | 2.23432566 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.18127894 |
| 30 | MP0010630_abnormal_cardiac_muscle | 2.14917666 |
| 31 | MP0000750_abnormal_muscle_regeneration | 2.10953622 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 2.08923592 |
| 33 | MP0002723_abnormal_immune_serum | 2.07324448 |
| 34 | MP0004036_abnormal_muscle_relaxation | 2.07324216 |
| 35 | MP0005666_abnormal_adipose_tissue | 2.02095536 |
| 36 | MP0009785_altered_susceptibility_to | 2.02068983 |
| 37 | MP0005330_cardiomyopathy | 2.01913724 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.99029275 |
| 39 | MP0000747_muscle_weakness | 1.98912120 |
| 40 | MP0001819_abnormal_immune_cell | 1.96782743 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.96767808 |
| 42 | MP0002106_abnormal_muscle_physiology | 1.93896238 |
| 43 | MP0000759_abnormal_skeletal_muscle | 1.91352875 |
| 44 | MP0009278_abnormal_bone_marrow | 1.88962047 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.85973330 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.84223980 |
| 47 | MP0002269_muscular_atrophy | 1.82303700 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.79857446 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.77340914 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.75498966 |
| 51 | MP0004233_abnormal_muscle_weight | 1.74393889 |
| 52 | MP0004215_abnormal_myocardial_fiber | 1.73820749 |
| 53 | MP0008260_abnormal_autophagy | 1.71782545 |
| 54 | MP0002405_respiratory_system_inflammati | 1.68569941 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.67113966 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.63879409 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.63107650 |
| 58 | MP0000604_amyloidosis | 1.60809896 |
| 59 | MP0005670_abnormal_white_adipose | 1.58928764 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.57643876 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.56104546 |
| 62 | MP0000716_abnormal_immune_system | 1.54120374 |
| 63 | MP0003075_altered_response_to | 1.50531952 |
| 64 | MP0000858_altered_metastatic_potential | 1.48615244 |
| 65 | * MP0003566_abnormal_cell_adhesion | 1.47380628 |
| 66 | MP0005369_muscle_phenotype | 1.47318507 |
| 67 | MP0003279_aneurysm | 1.46679052 |
| 68 | MP0001544_abnormal_cardiovascular_syste | 1.44754033 |
| 69 | MP0005385_cardiovascular_system_phenoty | 1.44754033 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.44382501 |
| 71 | MP0005620_abnormal_muscle_contractility | 1.40661752 |
| 72 | MP0008775_abnormal_heart_ventricle | 1.39033645 |
| 73 | MP0001853_heart_inflammation | 1.38168984 |
| 74 | MP0005310_abnormal_salivary_gland | 1.33601370 |
| 75 | MP0002972_abnormal_cardiac_muscle | 1.33000636 |
| 76 | MP0003690_abnormal_glial_cell | 1.32876153 |
| 77 | MP0003828_pulmonary_edema | 1.32770937 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.29716232 |
| 79 | MP0000343_altered_response_to | 1.28763167 |
| 80 | MP0003045_fibrosis | 1.28326394 |
| 81 | MP0003763_abnormal_thymus_physiology | 1.27083117 |
| 82 | MP0000685_abnormal_immune_system | 1.27040146 |
| 83 | MP0010368_abnormal_lymphatic_system | 1.26356002 |
| 84 | MP0000569_abnormal_digit_pigmentation | 1.26183841 |
| 85 | * MP0003091_abnormal_cell_migration | 1.25164189 |
| 86 | MP0002429_abnormal_blood_cell | 1.21899150 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 1.21487576 |
| 88 | MP0000689_abnormal_spleen_morphology | 1.20206354 |
| 89 | MP0000266_abnormal_heart_morphology | 1.17993989 |
| 90 | MP0002722_abnormal_immune_system | 1.17988499 |
| 91 | MP0003448_altered_tumor_morphology | 1.17230828 |
| 92 | MP0008438_abnormal_cutaneous_collagen | 1.16497749 |
| 93 | MP0008469_abnormal_protein_level | 1.15721087 |
| 94 | MP0005166_decreased_susceptibility_to | 1.15593301 |
| 95 | MP0001545_abnormal_hematopoietic_system | 1.13884858 |
| 96 | MP0001348_abnormal_lacrimal_gland | 1.12714503 |
| 97 | MP0003329_amyloid_beta_deposits | 1.11954562 |
| 98 | MP0004859_abnormal_synaptic_plasticity | 1.10714251 |
| 99 | MP0009764_decreased_sensitivity_to | 1.08399197 |
| 100 | MP0002925_abnormal_cardiovascular_devel | 1.08393960 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 1.07490779 |
| 102 | MP0001849_ear_inflammation | 1.06649838 |
| 103 | MP0006138_congestive_heart_failure | 1.04421952 |
| 104 | MP0000013_abnormal_adipose_tissue | 1.04010632 |
| 105 | MP0003137_abnormal_impulse_conducting | 1.01932392 |
| 106 | MP0001873_stomach_inflammation | 1.01519813 |
| 107 | MP0004484_altered_response_of | 1.00294103 |
| 108 | * MP0002128_abnormal_blood_circulation | 0.99772053 |
| 109 | MP0002933_joint_inflammation | 0.99536367 |
| 110 | MP0002166_altered_tumor_susceptibility | 0.98352417 |
| 111 | MP0003183_abnormal_peptide_metabolism | 0.97279015 |
| 112 | MP0001851_eye_inflammation | 0.97113478 |
| 113 | MP0009780_abnormal_chondrocyte_physiolo | 0.96752237 |
| 114 | MP0005023_abnormal_wound_healing | 0.96349173 |
| 115 | MP0000703_abnormal_thymus_morphology | 0.95306070 |
| 116 | MP0002909_abnormal_adrenal_gland | 0.94786782 |
| 117 | MP0001800_abnormal_humoral_immune | 0.94040543 |
| 118 | MP0004197_abnormal_fetal_growth/weight/ | 0.93607256 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 0.93242506 |
| 120 | MP0002088_abnormal_embryonic_growth/wei | 0.93191407 |
| 121 | MP0002138_abnormal_hepatobiliary_system | 0.93076976 |
| 122 | MP0003984_embryonic_growth_retardation | 0.92994129 |
| 123 | MP0000465_gastrointestinal_hemorrhage | 0.91891131 |
| 124 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91334992 |
| 125 | MP0004858_abnormal_nervous_system | 0.91128363 |
| 126 | MP0005387_immune_system_phenotype | 0.90013225 |
| 127 | MP0001790_abnormal_immune_system | 0.90013225 |
| 128 | MP0005409_darkened_coat_color | 0.89620003 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.88766258 |
| 130 | MP0010234_abnormal_vibrissa_follicle | 0.88746348 |
| 131 | MP0005187_abnormal_penis_morphology | 0.87966112 |
| 132 | MP0002254_reproductive_system_inflammat | 0.87960407 |
| 133 | MP0001879_abnormal_lymphatic_vessel | 0.87065104 |
| 134 | MP0004381_abnormal_hair_follicle | 0.86989391 |
| 135 | MP0008770_decreased_survivor_rate | 0.86645914 |
| 136 | MP0000249_abnormal_blood_vessel | 0.85253470 |
| 137 | MP0002234_abnormal_pharynx_morphology | 0.85057717 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.84122200 |
| 139 | MP0003866_abnormal_defecation | 0.83882697 |
| 140 | MP0004883_abnormal_blood_vessel | 0.83415523 |
| 141 | MP0008874_decreased_physiological_sensi | 0.82269529 |
| 142 | MP0002398_abnormal_bone_marrow | 0.81929844 |
| 143 | MP0002971_abnormal_brown_adipose | 0.80781364 |
| 144 | MP0002086_abnormal_extraembryonic_tissu | 0.80558963 |
| 145 | MP0002396_abnormal_hematopoietic_system | 0.79495111 |
| 146 | MP0002127_abnormal_cardiovascular_syste | 0.77708077 |
| 147 | MP0004085_abnormal_heartbeat | 0.77691189 |
| 148 | MP0001915_intracranial_hemorrhage | 0.77659916 |
| 149 | * MP0000767_abnormal_smooth_muscle | 0.77460968 |
| 150 | MP0005390_skeleton_phenotype | 0.76391111 |
| 151 | MP0001730_embryonic_growth_arrest | 0.75582624 |
| 152 | MP0000920_abnormal_myelination | 0.74499807 |
| 153 | MP0001672_abnormal_embryogenesis/_devel | 0.72507913 |
| 154 | MP0005380_embryogenesis_phenotype | 0.72507913 |
| 155 | MP0004947_skin_inflammation | 0.72276654 |
| 156 | MP0008004_abnormal_stomach_pH | 0.72159499 |
| 157 | * MP0001784_abnormal_fluid_regulation | 0.71404168 |
| 158 | MP0001958_emphysema | 0.71143985 |
| 159 | MP0001663_abnormal_digestive_system | 0.70938053 |
| 160 | MP0003795_abnormal_bone_structure | 0.70840079 |
| 161 | MP0009672_abnormal_birth_weight | 0.70263376 |
| 162 | MP0002108_abnormal_muscle_morphology | 0.68363257 |
| 163 | MP0009115_abnormal_fat_cell | 0.67258456 |
| 164 | MP0005397_hematopoietic_system_phenotyp | 0.66677094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.63650957 |
| 2 | Difficulty running (HP:0009046) | 4.04727211 |
| 3 | Abnormality of macrophages (HP:0004311) | 3.95149189 |
| 4 | Hyporeflexia of lower limbs (HP:0002600) | 3.93639564 |
| 5 | Increased connective tissue (HP:0009025) | 3.91456361 |
| 6 | Sudden death (HP:0001699) | 3.76274918 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.73354329 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.72216550 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.72216550 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.72216550 |
| 11 | Exercise-induced myalgia (HP:0003738) | 3.68109973 |
| 12 | Recurrent abscess formation (HP:0002722) | 3.63392273 |
| 13 | Cerebral aneurysm (HP:0004944) | 3.49951897 |
| 14 | Muscle fiber splitting (HP:0003555) | 3.49527565 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 3.43448529 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 3.21691286 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.12417749 |
| 18 | Difficulty climbing stairs (HP:0003551) | 3.11246811 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.08577382 |
| 20 | Hyperacusis (HP:0010780) | 3.03966262 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.00238191 |
| 22 | Cellulitis (HP:0100658) | 2.97945841 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.97352438 |
| 24 | Spontaneous hematomas (HP:0007420) | 2.95690096 |
| 25 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.88426559 |
| 26 | Subaortic stenosis (HP:0001682) | 2.88426559 |
| 27 | Muscle fiber inclusion bodies (HP:0100299) | 2.83909510 |
| 28 | Ventricular tachycardia (HP:0004756) | 2.80534783 |
| 29 | Myositis (HP:0100614) | 2.76213080 |
| 30 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.75963491 |
| 31 | Myoglobinuria (HP:0002913) | 2.73333970 |
| 32 | Gastrointestinal stroma tumor (HP:0100723) | 2.73232999 |
| 33 | EMG: myopathic abnormalities (HP:0003458) | 2.72993306 |
| 34 | Dysmetric saccades (HP:0000641) | 2.72521492 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 2.72374383 |
| 36 | Protrusio acetabuli (HP:0003179) | 2.72019075 |
| 37 | Meningitis (HP:0001287) | 2.70281810 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.69371319 |
| 39 | Orchitis (HP:0100796) | 2.69151685 |
| 40 | Calf muscle hypertrophy (HP:0008981) | 2.68141151 |
| 41 | Bundle branch block (HP:0011710) | 2.66054108 |
| 42 | Recurrent fungal infections (HP:0002841) | 2.62173522 |
| 43 | Increased density of long bones (HP:0006392) | 2.61999339 |
| 44 | Recurrent viral infections (HP:0004429) | 2.61879610 |
| 45 | Achilles tendon contracture (HP:0001771) | 2.61282070 |
| 46 | Lower limb amyotrophy (HP:0007210) | 2.56244168 |
| 47 | Shallow orbits (HP:0000586) | 2.56219324 |
| 48 | Frequent falls (HP:0002359) | 2.55737634 |
| 49 | Abnormality of the calf musculature (HP:0001430) | 2.55474473 |
| 50 | Distal lower limb amyotrophy (HP:0008944) | 2.54532510 |
| 51 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.54293565 |
| 52 | Asymmetric septal hypertrophy (HP:0001670) | 2.52702977 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.51490606 |
| 54 | Loss of speech (HP:0002371) | 2.49226084 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.48547693 |
| 56 | Optic neuritis (HP:0100653) | 2.48547693 |
| 57 | Gingivitis (HP:0000230) | 2.47441809 |
| 58 | Increased IgE level (HP:0003212) | 2.46769782 |
| 59 | Scapular winging (HP:0003691) | 2.44610570 |
| 60 | Obstructive lung disease (HP:0006536) | 2.44130751 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44130751 |
| 62 | Vasculitis (HP:0002633) | 2.42431634 |
| 63 | Rectal prolapse (HP:0002035) | 2.41012647 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.40817465 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.40452498 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.40098325 |
| 67 | Round ear (HP:0100830) | 2.39926840 |
| 68 | Recurrent skin infections (HP:0001581) | 2.36717008 |
| 69 | Limb-girdle muscle atrophy (HP:0003797) | 2.35580839 |
| 70 | Myocardial infarction (HP:0001658) | 2.33147616 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 2.32028722 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.31648887 |
| 73 | Mitral valve prolapse (HP:0001634) | 2.30577223 |
| 74 | Mucopolysacchariduria (HP:0008155) | 2.30245770 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30245770 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.29296905 |
| 77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29070106 |
| 78 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29070106 |
| 79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29070106 |
| 80 | Right ventricular cardiomyopathy (HP:0011663) | 2.27377741 |
| 81 | Neurofibrillary tangles (HP:0002185) | 2.26926197 |
| 82 | Distal upper limb amyotrophy (HP:0007149) | 2.26196806 |
| 83 | Upper limb amyotrophy (HP:0009129) | 2.26196806 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.24628294 |
| 85 | Lymphangioma (HP:0100764) | 2.23949465 |
| 86 | Restrictive lung disease (HP:0002091) | 2.19870796 |
| 87 | Emphysema (HP:0002097) | 2.18935417 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.17904017 |
| 89 | Obstructive sleep apnea (HP:0002870) | 2.17629701 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17175559 |
| 91 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17175559 |
| 92 | Macroorchidism (HP:0000053) | 2.15040080 |
| 93 | Lipoatrophy (HP:0100578) | 2.14751435 |
| 94 | Aneurysm (HP:0002617) | 2.14334099 |
| 95 | Broad metatarsal (HP:0001783) | 2.13621273 |
| 96 | Atrial fibrillation (HP:0005110) | 2.13252368 |
| 97 | Ulnar deviation of the wrist (HP:0003049) | 2.12593751 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 2.12123523 |
| 99 | Primary atrial arrhythmia (HP:0001692) | 2.11314770 |
| 100 | Elfin facies (HP:0004428) | 2.10632839 |
| 101 | Myotonia (HP:0002486) | 2.10362714 |
| 102 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.09596105 |
| 103 | Chest pain (HP:0100749) | 2.08326855 |
| 104 | EMG: neuropathic changes (HP:0003445) | 2.07542949 |
| 105 | Atrioventricular block (HP:0001678) | 2.05989374 |
| 106 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.05568527 |
| 107 | Nemaline bodies (HP:0003798) | 2.05442250 |
| 108 | Pulmonary infiltrates (HP:0002113) | 2.04819052 |
| 109 | T lymphocytopenia (HP:0005403) | 2.04327598 |
| 110 | Supraventricular arrhythmia (HP:0005115) | 2.03531453 |
| 111 | Verrucae (HP:0200043) | 2.03126061 |
| 112 | Papilloma (HP:0012740) | 2.03126061 |
| 113 | Abnormality of the nasal mucosa (HP:0000433) | 2.02772467 |
| 114 | Distal lower limb muscle weakness (HP:0009053) | 2.01424982 |
| 115 | Cerebral inclusion bodies (HP:0100314) | 2.01305938 |
| 116 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.00633663 |
| 117 | Supraventricular tachycardia (HP:0004755) | 1.99227714 |
| 118 | Slow saccadic eye movements (HP:0000514) | 1.98730117 |
| 119 | Osteomyelitis (HP:0002754) | 1.98629135 |
| 120 | Thoracic kyphosis (HP:0002942) | 1.97962717 |
| 121 | Subacute progressive viral hepatitis (HP:0006572) | 1.96462757 |
| 122 | Thin bony cortex (HP:0002753) | 1.95996285 |
| 123 | Nasal polyposis (HP:0100582) | 1.93566522 |
| 124 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93501609 |
| 125 | Aortic aneurysm (HP:0004942) | 1.93021642 |
| 126 | Stomatitis (HP:0010280) | 1.92662314 |
| 127 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.92548485 |
| 128 | Short 4th metacarpal (HP:0010044) | 1.92548485 |
| 129 | Pointed chin (HP:0000307) | 1.92082431 |
| 130 | Amyloidosis (HP:0011034) | 1.91878108 |
| 131 | Hemoptysis (HP:0002105) | 1.91041666 |
| 132 | Fatigue (HP:0012378) | 1.90421340 |
| 133 | Abnormal atrioventricular conduction (HP:0005150) | 1.89953823 |
| 134 | Abnormality of the lower motor neuron (HP:0002366) | 1.89393027 |
| 135 | Abnormality of the fingertips (HP:0001211) | 1.88647532 |
| 136 | Myopathic facies (HP:0002058) | 1.88581549 |
| 137 | Heart block (HP:0012722) | 1.88434043 |
| 138 | Insomnia (HP:0100785) | 1.86485561 |
| 139 | Distal arthrogryposis (HP:0005684) | 1.86338120 |
| 140 | Abnormality of the 4th metacarpal (HP:0010012) | 1.85768692 |
| 141 | Urticaria (HP:0001025) | 1.85718116 |
| 142 | Purpura (HP:0000979) | 1.85637055 |
| 143 | Renovascular hypertension (HP:0100817) | 1.85179503 |
| 144 | Dilatation of the ascending aorta (HP:0005111) | 1.84688789 |
| 145 | Colitis (HP:0002583) | 1.84517832 |
| 146 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.83860827 |
| 147 | Interstitial pulmonary disease (HP:0006530) | 1.81802759 |
| 148 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81570996 |
| 149 | Disinhibition (HP:0000734) | 1.81430497 |
| 150 | Pelvic girdle muscle weakness (HP:0003749) | 1.79091655 |
| 151 | Apathy (HP:0000741) | 1.79008521 |
| 152 | Genu recurvatum (HP:0002816) | 1.78585275 |
| 153 | Vertebral arch anomaly (HP:0008438) | 1.77962756 |
| 154 | Bowel diverticulosis (HP:0005222) | 1.77923697 |
| 155 | Viral hepatitis (HP:0006562) | 1.77871736 |
| 156 | Broad face (HP:0000283) | 1.77747432 |
| 157 | Lymphopenia (HP:0001888) | 1.77433136 |
| 158 | Bladder diverticulum (HP:0000015) | 1.76081227 |
| 159 | Keratoconjunctivitis sicca (HP:0001097) | 1.75839368 |
| 160 | Persistence of primary teeth (HP:0006335) | 1.75565908 |
| 161 | Hematochezia (HP:0002573) | 1.74690396 |
| 162 | Supranuclear gaze palsy (HP:0000605) | 1.74631008 |
| 163 | Abnormality of T cell number (HP:0011839) | 1.74388170 |
| 164 | Pustule (HP:0200039) | 1.74320815 |
| 165 | Limb-girdle muscle weakness (HP:0003325) | 1.74301106 |
| 166 | Arterial thrombosis (HP:0004420) | 1.73493569 |
| 167 | Epistaxis (HP:0000421) | 1.73147832 |
| 168 | Panhypogammaglobulinemia (HP:0003139) | 1.71810981 |
| 169 | Axonal loss (HP:0003447) | 1.71482870 |
| 170 | Encephalitis (HP:0002383) | 1.71090772 |
| 171 | Diminished motivation (HP:0000745) | 1.70577203 |
| 172 | Rhabdomyolysis (HP:0003201) | 1.70468488 |
| 173 | Polygenic inheritance (HP:0010982) | 1.69862433 |
| 174 | Abnormality of the thoracic spine (HP:0100711) | 1.69810492 |
| 175 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.69794446 |
| 176 | Hand muscle atrophy (HP:0009130) | 1.68902954 |
| 177 | Enlarged penis (HP:0000040) | 1.68746074 |
| 178 | Proximal amyotrophy (HP:0007126) | 1.67031631 |
| 179 | Striae distensae (HP:0001065) | 1.66584327 |
| 180 | Fibroma (HP:0010614) | 1.65532917 |
| 181 | Facial diplegia (HP:0001349) | 1.65269218 |
| 182 | Ulnar bowing (HP:0003031) | 1.64576838 |
| 183 | Fibrous tissue neoplasm (HP:0012316) | 1.64336625 |
| 184 | Ankle contracture (HP:0006466) | 1.64264965 |
| 185 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.63624501 |
| 186 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.63624501 |
| 187 | Hypercortisolism (HP:0001578) | 1.63076098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.97541488 |
| 2 | PRPF4B | 4.08557933 |
| 3 | PKN2 | 3.95636056 |
| 4 | TTN | 3.69699253 |
| 5 | EEF2K | 3.25271438 |
| 6 | RIPK4 | 3.05692271 |
| 7 | MAP3K10 | 2.91177955 |
| 8 | RIPK1 | 2.83441997 |
| 9 | IRAK3 | 2.41809859 |
| 10 | BLK | 2.26576035 |
| 11 | MAP4K1 | 2.26177333 |
| 12 | MAP3K13 | 2.25272359 |
| 13 | MAP3K14 | 2.22852992 |
| 14 | ICK | 2.16768058 |
| 15 | DMPK | 2.11113064 |
| 16 | CDK12 | 2.02409335 |
| 17 | SMG1 | 1.83199779 |
| 18 | SIK2 | 1.78334102 |
| 19 | SIK1 | 1.74195162 |
| 20 | PDGFRA | 1.64250519 |
| 21 | TAOK1 | 1.62987876 |
| 22 | IRAK4 | 1.62242129 |
| 23 | PTK6 | 1.61940442 |
| 24 | PHKG1 | 1.60085650 |
| 25 | PHKG2 | 1.60085650 |
| 26 | ERN1 | 1.56262044 |
| 27 | ALK | 1.51817224 |
| 28 | TYRO3 | 1.43100448 |
| 29 | PRKD3 | 1.43098781 |
| 30 | MAP3K7 | 1.41545285 |
| 31 | FGFR4 | 1.35365532 |
| 32 | FGFR3 | 1.35102590 |
| 33 | CAMK1G | 1.23666424 |
| 34 | TAOK2 | 1.23372599 |
| 35 | OBSCN | 1.22651864 |
| 36 | PRKCH | 1.18129500 |
| 37 | LRRK2 | 1.16318776 |
| 38 | FGR | 1.15519466 |
| 39 | MAP2K3 | 1.13570001 |
| 40 | MAP3K1 | 1.12024281 |
| 41 | BMX | 1.11924585 |
| 42 | IKBKE | 1.11017030 |
| 43 | MTOR | 1.07374461 |
| 44 | CAMK1D | 1.05259621 |
| 45 | EPHB1 | 1.01216494 |
| 46 | SIK3 | 0.94238316 |
| 47 | TNK2 | 0.91719184 |
| 48 | NEK9 | 0.90794940 |
| 49 | MOS | 0.90163419 |
| 50 | JAK1 | 0.89745274 |
| 51 | RET | 0.88118828 |
| 52 | MATK | 0.87890589 |
| 53 | STK10 | 0.87757138 |
| 54 | GRK6 | 0.87016171 |
| 55 | PRKD1 | 0.84701560 |
| 56 | JAK3 | 0.82332032 |
| 57 | MARK2 | 0.81221139 |
| 58 | CSK | 0.80788808 |
| 59 | PDGFRB | 0.79712493 |
| 60 | TGFBR2 | 0.79700282 |
| 61 | RPS6KL1 | 0.77289629 |
| 62 | RPS6KC1 | 0.77289629 |
| 63 | MAPK7 | 0.77172429 |
| 64 | IKBKB | 0.76264629 |
| 65 | IRAK2 | 0.75511336 |
| 66 | PAK6 | 0.73441294 |
| 67 | LYN | 0.73115525 |
| 68 | STK24 | 0.72537440 |
| 69 | STK38 | 0.71766621 |
| 70 | LCK | 0.71538689 |
| 71 | NEK1 | 0.71246960 |
| 72 | PDK1 | 0.71207286 |
| 73 | CDK6 | 0.71124166 |
| 74 | PRKD2 | 0.70405617 |
| 75 | STK11 | 0.69432640 |
| 76 | CAMKK1 | 0.69313630 |
| 77 | LMTK2 | 0.68931639 |
| 78 | CDC42BPA | 0.67842576 |
| 79 | MAPK12 | 0.67720871 |
| 80 | DDR2 | 0.65657955 |
| 81 | PAK2 | 0.65292756 |
| 82 | NME2 | 0.64707388 |
| 83 | KSR2 | 0.62659471 |
| 84 | MAP3K9 | 0.61202412 |
| 85 | ARAF | 0.60292484 |
| 86 | PDK3 | 0.60224858 |
| 87 | PDK4 | 0.60224858 |
| 88 | CHUK | 0.59742349 |
| 89 | * HCK | 0.59280172 |
| 90 | RPS6KA2 | 0.59217427 |
| 91 | DYRK1B | 0.59157240 |
| 92 | MARK3 | 0.58341058 |
| 93 | TYK2 | 0.58052580 |
| 94 | RPS6KA6 | 0.57016777 |
| 95 | JAK2 | 0.56745721 |
| 96 | ILK | 0.56591779 |
| 97 | CSF1R | 0.56101420 |
| 98 | ZAP70 | 0.55971828 |
| 99 | RPS6KA1 | 0.55820836 |
| 100 | ITK | 0.55788840 |
| 101 | KIT | 0.55630572 |
| 102 | PTK2B | 0.55134305 |
| 103 | LATS2 | 0.55056994 |
| 104 | FGFR1 | 0.54699513 |
| 105 | PDPK1 | 0.54648419 |
| 106 | FES | 0.53880784 |
| 107 | HIPK2 | 0.53072012 |
| 108 | TXK | 0.52772070 |
| 109 | CDK4 | 0.52746889 |
| 110 | GRK7 | 0.51429498 |
| 111 | SGK3 | 0.50173841 |
| 112 | PAK4 | 0.49890001 |
| 113 | MAPK4 | 0.47656218 |
| 114 | SCYL2 | 0.46949061 |
| 115 | TBK1 | 0.46736299 |
| 116 | MAP3K8 | 0.46237906 |
| 117 | MAP3K2 | 0.45206194 |
| 118 | TRPM7 | 0.44766885 |
| 119 | PTK2 | 0.43414901 |
| 120 | MAP3K11 | 0.43260507 |
| 121 | LATS1 | 0.43007410 |
| 122 | PRKAA1 | 0.42932584 |
| 123 | BMPR2 | 0.42741909 |
| 124 | AKT2 | 0.42464216 |
| 125 | IRAK1 | 0.41286676 |
| 126 | FYN | 0.40939952 |
| 127 | TIE1 | 0.40937086 |
| 128 | NEK2 | 0.39877111 |
| 129 | BRD4 | 0.39790164 |
| 130 | MAP3K3 | 0.38907490 |
| 131 | PAK3 | 0.36914547 |
| 132 | CAMK4 | 0.36893154 |
| 133 | BTK | 0.36074895 |
| 134 | FGFR2 | 0.35504154 |
| 135 | SYK | 0.35187668 |
| 136 | RPS6KA4 | 0.35132725 |
| 137 | MARK1 | 0.34009343 |
| 138 | MAPK11 | 0.33606452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.35317324 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.16382408 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96063254 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95961744 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.92457655 |
| 6 | Viral myocarditis_Homo sapiens_hsa05416 | 1.90368340 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 1.88305872 |
| 8 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.83577130 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.81716432 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78185666 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.75496082 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.75085022 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.69416852 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.68187456 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57286320 |
| 16 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.56696874 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.56449051 |
| 18 | Insulin resistance_Homo sapiens_hsa04931 | 1.48047846 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.45865949 |
| 20 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.44931608 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43644424 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42215853 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.39549278 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37788796 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35204021 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34076643 |
| 27 | Lysine degradation_Homo sapiens_hsa00310 | 1.33471861 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33347305 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.31488979 |
| 30 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.30421306 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30190854 |
| 32 | * Focal adhesion_Homo sapiens_hsa04510 | 1.29297742 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28287038 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.28266728 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.28076323 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27486079 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.26864880 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26765139 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26659538 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.24848894 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24777146 |
| 42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.24228535 |
| 43 | Endometrial cancer_Homo sapiens_hsa05213 | 1.22564143 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.21317265 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19612040 |
| 46 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18775433 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.18770368 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17719921 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17140516 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.16906931 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.16725590 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16689560 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16556348 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.15485575 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.15121387 |
| 56 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.14998401 |
| 57 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.13686747 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13119267 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12088980 |
| 60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.11733231 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 1.11593818 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09875773 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 1.09747761 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09543203 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09066877 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08643205 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 1.08572462 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 1.07680637 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07156817 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07015551 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06658211 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.06581894 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00747230 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.99531425 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98882702 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.98201672 |
| 77 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97789556 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.96775979 |
| 79 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96470512 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96418254 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96171872 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.94328784 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.92041631 |
| 84 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91672226 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90006489 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.89710243 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86023980 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85481537 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.85182262 |
| 90 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84410683 |
| 91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.83144224 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83135120 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81982310 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81827702 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80671576 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80542963 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80225756 |
| 98 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78057479 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77154703 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76481775 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75976352 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.75208331 |
| 103 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73908349 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71832056 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.70544052 |
| 106 | Hepatitis B_Homo sapiens_hsa05161 | 0.70059479 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69365205 |
| 108 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68399927 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67849532 |
| 110 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67719023 |
| 111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65883698 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.65209671 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64245159 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.63970868 |
| 115 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62663916 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.62202985 |
| 117 | Apoptosis_Homo sapiens_hsa04210 | 0.61987305 |
| 118 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61837222 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58766995 |
| 120 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57531578 |
| 121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56153443 |
| 122 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55992060 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.55227243 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55054630 |
| 125 | Circadian entrainment_Homo sapiens_hsa04713 | 0.54537224 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.54247446 |
| 127 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53865069 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53792540 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.53694209 |
| 130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53592877 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53549260 |
| 132 | Melanogenesis_Homo sapiens_hsa04916 | 0.53503189 |
| 133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53375586 |
| 134 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53125482 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52595742 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52553176 |
| 137 | Measles_Homo sapiens_hsa05162 | 0.52324821 |

